Active bacterial core surveillance of the emerging infections program network

被引:184
作者
Schuchat, A
Hilger, T
Zell, E
Farley, MM
Reingold, A
Harrison, L
Lefkowitz, L
Danila, R
Stefonek, K
Barrett, N
Morse, D
Pinner, R
机构
[1] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA
[2] Emory Univ, Sch Med, Georgia Emerging Infect Program, Georgia Dept Human Resources,Div Publ Hlth, Atlanta, GA USA
[3] Atlanta Vet Adm Med Ctr, Atlanta, GA USA
[4] Calif Dept Hlth Serv, Berkeley, CA 94704 USA
[5] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA
[6] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA
[7] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA
[8] Tennessee Dept Hlth, Nashville, TN USA
[9] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[10] Minnesota Dept Hlth, St Paul, MN USA
[11] Oregon Dept Human Resources, Portland, OR USA
[12] Connecticut Dept Publ Hlth, Hartford, CT USA
[13] New York State Dept Hlth, Albany, NY USA
关键词
D O I
10.3201/eid0701.010114
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Active Bacterial Core surveillance (ABCs) is a collaboration between the Centers for Disease Control and Prevention and several state health departments and universities participating in the Emerging Infections Program Network. ABCs conducts population-based active surveillance, collects isolates, and performs studies of invasive disease caused by Streptococcus pneumoniae, group A and group B Streptococcus, Neisseria meningitidis, and Haemophilus influenzae for a population of 17 to 30 million. These pathogens caused an estimated 97,000 invasive cases, resulting in 10,000 deaths in the United States in 1998. Incidence rates of these pathogens are described. During 1998, 25% of invasive pneumococcal infections in ABCs areas were not susceptible to penicillin, and 13.3% were not susceptible to three classes of antibiotics. in 1998, early-onset group B streptococcal disease had declined by 65% over the previous 6 years. More information on ABCs is available at www.cdc.gov/ncidod/dbmd/abcs. ABCs specimens will soon be available to researchers through an archive.
引用
收藏
页码:92 / 99
页数:8
相关论文
共 41 条
[1]   DECLINE OF CHILDHOOD HAEMOPHILUS-INFLUENZAE TYPE-B (HIB) DISEASE IN THE HIB VACCINE ERA [J].
ADAMS, WG ;
DEAVER, KA ;
COCHI, SL ;
PLIKAYTIS, BD ;
ZELL, ER ;
BROOME, CV ;
WENGER, JD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (02) :221-226
[2]  
[Anonymous], 1997, MMWR Recomm Rep, V46, P1
[3]  
[Anonymous], 1996, MMWR Recomm Rep, V45, P1
[4]  
[Anonymous], 1994, MORBIDITY MORTALITY
[5]   Sequencing emm-specific PCR products for routine and accurate typing of group a streptococci [J].
Beall, B ;
Facklam, R ;
Thompson, T .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) :953-958
[6]   Invasive group B streptococcal disease: The emergence of serotype V [J].
Blumberg, HM ;
Stephens, DS ;
Modansky, M ;
Erwin, M ;
Elliot, J ;
Facklam, RR ;
Schuchat, A ;
Baughman, W ;
Farley, MM .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (02) :365-373
[7]  
*CDCP, 1998, PREV EM INF DIS STRA
[8]  
*CDCP, 1999, MMWR-MORBID MORTAL W, V48, P426
[9]  
Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P258
[10]  
Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P665